by Yael Tamar
The problem we solve: According to a recent survey, over 50% of cancer survivors delayed seeking treatment for over 2 months and over 15% waited 1 to 5 years. In total, 81% (1) decided to ignore symptoms, (2) de-prioritized care or (3) were anxious to see the doctor, which resulted in delay in seeking treatment. This has a hugely negative effect on treatment outcome because the illness will have progressed by the time the patient sees the doctor and performs the necessary tests.
About our solution: Aug-Mental, is an AI platform that helps provide insights from patients' behavioral data using wearable devices to detect deviations in their unique behavioral pattern. Our initial focus is early detection of depression in the elderly.
Progress to date:TECH TRACTION
-MADE ARCHITECTURE PLAN
-FITBIT API CONNECTED
-DATABASE CREATED
-WEB APP FOR COLLECTING FITBIT DATA CREATED
-PARTNERSHIP WITH NEURA - HEALTH AI COMPANY
DATA TRACTION
-COLLECTED DATA FROM A DOZEN USERS
-ANALYZED SCIENTIFIC LITERATURE
-CREATE FRAMEWORK FOR DATA ANALYSIS
-ANALYZED DATA FROM USERS
-ASKED USERS FOR VERIFICATION OF DATA ANALYSIS
-RECRUITEDD MENTAL AND PHYSICAL HEALTH PROFESSIONALS TO OUR BOARD
Creator: Yael Tamar
Location: Tarapacá
Bio: Health entrepreneur, Marketing and Biz Dev Executive and startup founder since 2009. Into guitar, singing and song-writing, salsa and hip-hop dancing and vegan cooking. Crazy mom of two kids under 5.
Title: Cofounder and CEO
Advanced Degree(s): M.A. in Economics
Aug-Mental
Location: Beit El 43
16
Tel Aviv, TA 69087
IL
Founded: 2016
Website: http://www.aug-mental.com
Blog: http://blog.aug-mental.com
Twitter: @AugMentalHealth
Facebook: https://www.facebook.com/augmentalhealth/
Product Stage: Prototype/MVP
YTD Sales: Working on it
Employees: 3-5
Market Size
We will help identify early signs of depression to prevent severe depression, help patients seek treatment and provide personalized advice on how to manage their depression.
Projected 3 Year Growth
We will help 1/3 of those suffering from depression whose depression is undiagnosed to get diagnosed
How We Will Make Money
We are building partnerships with different companies that provide AI solutions that would be useful in identifying patterns of disease, as well as companies that provide diagnostic devices and services. The added value for these partners would include access to data, ability to tap into additional AI resources and be a part of an en-to-end solution we will sell to customers. We will provide our customers, providers and payers, with healthcare AI solutions that solve specific medical challenges. We will mark these solutions up from the fee we pay to use the participating partners' APIs or SDKs and pocket the margin.About our Competition
Our competitors range from AI solution companies (Datu Health, Monsenso, Omada Health) to research/diagnostic platforms (Verily, FlowHealth, iCarbonX). Our competitors act like silos: they invest in their own clinical research and develop a specific methodology they offer to clients. What differentiates us is our crowdsourcing mechanism to leverage machine learning and research communities. We partnered with a machine learning community in China called Cruiser, and we are discussing a partnership with a Califirnia-based company collecting information on the clinical research done all around the world. We will leverage the research with our platform's data and get help from the machine learning community in solving challenges that are interesting to our customers. This mechanism will allow us to grow faster and solve more challenges and will make our platform more accurate and, at the same time, far-reaching.Intellectual Property Summary
Crowsourcing platorm for AI
Clinical Information
None needed
Regulatory Status
None needed
How we will use the funds raised
Software development
Pilot project
Business development
Thank You
We would really appreciate your support
Help us find best new ideas to fund by telling us what you think. Your feedback goes straight to the team behind this project in private, so tell them what you really think.